GALDY (Galderma Group AG) Marketable Securities : $0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Galderma Group AG's Marketable Securities for the quarter that ended in Dec. 2024 was $0 Mil.

Galderma Group AG Marketable Securities Historical Data

The historical data trend for Galderma Group AG's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Marketable Securities Chart

Galderma Group AG Annual Data

Trend

Dec23

Dec24

Marketable Securities

Galderma Group AG Semi-Annual Data
	Jun23	Dec23	Jun24	Dec24
Marketable Securities	-	-	-	-

Galderma Group AG Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Galderma Group AG (OTCPK:GALDY) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Galderma Group AG Marketable Securities Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » Marketable Securities

Traded in Other Exchanges

GDERF:USA GALDz:UK PY30:Germany GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.